Gene Generapy na Bunkasa Kasuwar Kula da Thalassaemiya ta Duniya

Incarin abin da ke faruwa na thalassaemia yana haifar da kasuwar gabaɗaya. Drugsara yawan bututun mai a cikin thalassaemia da haɓaka wayar da kan jama'a game da wadatattun hanyoyin magani kuma suna jan kasuwa. Yunƙurin da ake buƙata don ingantaccen maganin warkarwa kuma yana haɓaka kasuwar maganin Thalassemia.

Kasuwar Kula da Lafiya ta Duniya ta kai dala biliyan 2.3 a shekarar 2020 kuma an kiyasta ya kai dala biliyan 14.7 nan da shekarar 2030 kuma ana tsammanin yin rajistar CAGR na 10.40%.

Thalassaemia cuta ce ta jini da aka gada wanda ke da raguwar samarwar haemoglobin.

Kwayar cututtukan sun fara ne daga mara nauyi zuwa karancin jini wanda zai iya haifar da gajiya da kodadde fata tare da matsalolin kashi, kara girman ciki, fata mai launin rawaya, da fitsarin duhu. Akwai manyan nau'ikan guda biyu, alpha thalassaemia da beta thalassaemia. Bugu da ari, tsananin alpha da beta thalassaemia ya dogara da rashin ƙwayoyin halitta huɗu na alpha globin ko ƙwayoyin halitta biyu na beta globin. Ganewar asali yawanci shine ta gwajin jini ciki har da cikakken ƙidayar jini, gwajin haemoglobin na musamman da gwajin kwayar halitta.

Rahoton "Kasuwar Maganin Thalassaemiya ta Duniya, Ta Nau'in (Alpha-Thalassemia da Beta-Thalassaemia), Ta hanyar Jiyya (Jinyar Jini, Ciwon Kiran ƙarfe, Folarin Maganganun Acic, Gene Therapy da Kashi na Kashi), Ta -arshen Mai Amfani (Asibitoci & Clinics , Laburaren Binciko da Sauransu), da Yankin Yankin (Arewacin Amurka, Turai, Asiya Pacific, Latin Amurka, da Gabas ta Tsakiya & Afirka) - Hanyoyin Kasuwa, Nazari, da Hasashe har zuwa 2030 ”

Babban mahimman bayanai:

  • A watan Yunin 2019, Kamfanin Celgene da Acceleron Pharma Inc. sun ba da sanarwar cewa Hukumar Abinci da Magunguna ta Amurka (FDA) ta karɓi Aikace-aikacen lasisin Biologics na Celgene don wakili na bala'in erythroid mai suna Luspatercept don magance Beta-thalassaemia da ke tattare da cutar ƙarancin jini wanda ke buƙatar ƙarin RBC.
  • A watan Janairun 2019, Vifor Pharma ya fitar da rahoto mai kyau game da gwajin gwaji na lokaci-1 don mai hana shi ferroportin mai hanawa kuma batutuwa da ke kan hanya sun karɓi ƙwayoyi guda ɗaya na VIT-2763 (mai hana ferroportin) don maganin beta-thalassaemia.

Mahimman Bayanan Kasuwa daga rahoton:

Kasuwar Kula da Lafiya ta Duniya ta kai dala biliyan 2.3 a shekarar 2020 kuma an kiyasta ya kai dala biliyan 14.7 nan da shekarar 2030 kuma ana tsammanin yin rajistar CAGR na 10.40%. Kasuwar Kula da Thalassaemiya ta Duniya ta kasu kashi-kashi dangane da nau'in, magani, mai amfani da yankin da yanki.

  • Dangane da nau'ikan, an rarraba kasuwar Kula da Thalassaemiya ta Duniya zuwa Alpha-thalassaemia da Beta-thalassaemia.
  • Dangane da Jiyya, kasuwar da aka nufa ta kasu kashi biyu cikin Rarraba Jini, Magungunan Kiran ƙarfe, Karin Magungunan Acic, Jinyar Jini da Geneargaza Mararƙwara.
  • Dangane da mai amfani da ƙarshen, kasuwar hadahadar ta kasu kashi Asibitoci & Asibitoci, dakunan gwaje-gwaje da sauransu.
  • Ta yanki, an rarraba kasuwar Kula da Thalassaemiya ta Duniya zuwa Arewacin Amurka, Turai, Asiya Pacific, Latin Amurka, da Gabas ta Tsakiya & Afirka. Arewacin Amurka shine jagora a duk duniya a kasuwar maganin Thalassemia dangane da kudaden shiga, saboda tsarin kiwon lafiya da aka samu da kuma wayar da kan mutane game da kiwon lafiya.

    Dangane da Jiyya, kasuwar da aka nufa ta kasu kashi biyu cikin Rarraba Jini, Magungunan Kiran ƙarfe, Karin Magungunan Acic, Jinyar Jini da Geneargaza Mararƙwara.

Fasahar Gama gari:

Manyan 'yan wasan da ke aiki a Kasuwar Kula da Thalassemia ta Duniya sun hada da Novartis AG (Switzerland), Bluebird Bio, Inc. (US), Kiadis Pharma (Netherlands), CELGENE CORPORATION (US), Sangamo Therapeutics (US), Acceleron Pharma, Inc. ( US), Gamida Cell (Isra'ila).

The rahoton kasuwa yana ba da cikakken bayani game da tushen masana'antu, yawan aiki, ƙarfi, masana'antun, da abubuwan da ke faruwa kwanan nan waɗanda zasu taimaka wa kamfanoni faɗaɗa kasuwancin su da haɓaka haɓakar kuɗi. Bugu da ƙari kuma, rahoton yana nuna abubuwa masu ƙarfi waɗanda suka haɗa da sassa, ƙananan sassa, kasuwannin yanki, gasa, manyan 'yan wasa, da hasashen kasuwa. Bugu da kari, kasuwar ta hada da hadin gwiwa na baya-bayan nan, hadewa, saye-saye, da kawance tare da tsare-tsaren tsari a yankuna daban-daban da ke tasirin yanayin kasuwar. Cigaban fasahar zamani da kirkire-kirkire masu tasiri a kasuwar duniya suna cikin rahoton.

Samu rahoton kasuwa

Santosh M.

Ni dan kasuwar dijital ne a cikin fahimtar kasuwar annabci.
https://www.prophecymarketinsights.com/